High-purity Bremelanotide (PT-141) is a synthetic cyclic heptapeptide melanocortin agonist widely evaluated in preclinical literature for central signaling pathways. Investigators evaluating options to buy PT-141 Bremelanotide online require fully verified, analytical-grade compounds supported by lot-specific documentation. PX1 Research provides USA-manufactured research peptides designed strictly for in vitro and laboratory experimentation.
High-purity Bremelanotide (PT-141) is a synthetic cyclic heptapeptide melanocortin agonist widely evaluated in preclinical literature for central signaling pathways. Investigators evaluating options to buy PT-141 Bremelanotide online require fully verified, analytical-grade compounds supported by lot-specific documentation. PX1 Research provides USA-manufactured research peptides designed strictly for in vitro and laboratory experimentation.
When evaluating options to buy PT-141 Bremelanotide online for laboratory research, investigators must prioritize verified chemical identity, precise sequence integrity, and lot-specific analytical documentation. High-grade Bremelanotide reference materials require rigorous HPLC and mass spectrometry validation to ensure structural integrity and accurate assay results in preclinical melanocortin receptor studies.
PX1 Research supplies USA-manufactured PT-141 Bremelanotide 10mg synthesized under strict quality control protocols. Each production batch undergoes independent ISO 17025 laboratory verification to confirm purity levels exceeding 99%. By providing complete lot-traceability and comprehensive Certificates of Analysis (COAs), PX1 Research supports reproducible baseline data across biochemical, cell culture, and animal model research applications.
Bremelanotide, historically designated as PT-141, is a synthetic cyclic heptapeptide with the chemical sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH. Derived from the naturally occurring peptide hormone alpha-melanocyte-stimulating hormone (alpha-MSH), Bremelanotide possesses a lactam bridge structure that confers enhanced metabolic stability and enzymatic resistance compared to linear precursor peptides.
Pharmacologically, Bremelanotide acts as a non-selective melanocortin receptor agonist. Preclinical literature demonstrates high binding affinity for central melanocortin receptors, primarily the MC4R sub-type, as well as MC3R and MC1R. Unlike classic vasoactive agents, Bremelanotide modulates physiological pathways primarily through central nervous system signaling rather than direct peripheral vascular pathways. Detailed structural breakdowns and biochemical data are archived within the PX1 research library.
In preclinical rodent models, central administration of Bremelanotide has been shown to activate specific hypothalamic neuronal populations. Preclinical studies suggest that binding to MC4 receptors in the paraventricular nucleus (PVN) and medial preoptic area (mPOA) of the brain triggers downstream neurochemical cascades involving dopamine and oxytocin release. Consequently, the compound is heavily investigated for melanocortin-receptor signaling linked to sexual-health pathways and central autonomic regulation.
In vitro receptor-binding assays further confirm that Bremelanotide exhibits potent agonist activity, stimulating intracellular cyclic adenosine monophosphate (cAMP) accumulation in target cell lines expressing human MC4R. Researchers utilize these cellular models to investigate receptor internalization kinetics, desensitization phenomena, and selective signal transduction pathways.
Within melanocortin receptor research, several synthetic analogs are evaluated alongside PT-141 to map structural-activity relationships. Comparing Bremelanotide with related compounds reveals distinct binding profiles and receptor selectivity across the melanocortin family.
For instance, Melanotan II acts as a potent non-selective agonist across MC1R, MC3R, MC4R, and MC5R, frequently demonstrating potent skin pigmentation activity alongside central receptor activation. Conversely, Melanotan 1 (Afamelanotide) demonstrates higher selectivity for the peripheral MC1 receptor, making it a primary reference standard in melanogenesis assays. Bremelanotide (PT-141) differs fundamentally as a metabolite-derived structure optimized to reduce peripheral MC1R activity while maintaining central MC4R and MC3R engagement. Understanding these affinity nuances allows laboratory teams to select the appropriate control compound across our complete catalog of research peptides.
Maintaining rigorous experimental reproducibility requires research peptides free from synthesis side-products, truncated sequences, and residual organic solvents. Qualified peptide suppliers must demonstrate analytical purity through dual-verification methods, specifically High-Performance Liquid Chromatography (HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS).
Every batch of Bremelanotide produced for PX1 Research undergoes strict analytical testing at an accredited ISO 17025 third-party laboratory. HPLC analysis verifies chromatographic purity—ensuring the main peak area meets standard research requirements (>99%)—while mass spectrometry confirms the exact molecular weight (1024.2 g/mol). Researchers can access full lot documentation via our HPLC purity testing guide and public COA repository.
In cell culture models and sensitive in vitro bioassays, bacterial endotoxins (lipopolysaccharides) represent a significant confounding variable. High endotoxin levels can induce non-specific inflammatory signaling, alter cytokine secretion profiles, and compromise cell viability, invalidating target receptor data.
PX1 Research implements strict endotoxin testing protocols utilizing standard Limulus Amebocyte Lysate (LAL) assays. Batch results routinely document endotoxin levels far below industry thresholds (typically <0.01 EU/mg). This stringent quality control guarantees that observed cellular responses are attributable solely to Bremelanotide receptor interactions rather than artifactual contamination.
PT-141 Bremelanotide is supplied as a sterile, lyophilized (freeze-dried) white powder inside sealed borosilicate glass vials. To maintain peptide stability, proper laboratory reconstitution protocols must be followed strictly under aseptic conditions using a laminar flow hood.
For standard benchtop assays, lyophilized peptides are typically reconstituted using sterile Bacteriostatic Water (containing 0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS), depending on downstream application requirements. Researchers should allow the vial to reach room temperature prior to introducing diluent. Adding liquid gently along the glass wall without direct high-pressure spraying, followed by gentle swirling (avoiding vigorous vortexing), ensures complete dissolution without mechanical shear stress. Step-by-step calculations and vehicle choices can be reviewed in our reconstitution guide.
Peptide integrity is highly sensitive to ambient temperature, light exposure, and humidity. In freeze-dried form, PT-141 Bremelanotide remains stable at -20°C for extended periods (12 to 24 months). Desiccant packs should be kept in storage containers to prevent moisture accumulation upon opening secondary packaging.
Once reconstituted into aqueous solution, Bremelanotide should be stored at 2°C to 8°C and utilized within 30 days to minimize hydrolytic degradation. For longer-term storage of liquid stock solutions, working aliquots should be frozen immediately at -80°C. Avoiding repeated freeze-thaw cycles is critical to prevent peptide aggregation and loss of functional bioactivity.
Procuring research compounds from unreliable international sources carries significant risks, including batch-to-batch inconsistency, absent lot tracking, and mislabeled purity profiles. PX1 Research eliminates these vulnerabilities by manufacturing all peptides domestically in state-of-the-art, GMP-compliant facilities within the United States.
Orders are packed and dispatched directly from centralized distribution hubs located in California and Arizona. With same-day shipping offered Monday through Friday, academic laboratories, biotechnology firms, and institutional investigators receive research compounds rapidly and securely. Principal investigators interested in high-volume institutional procurement can apply for specialized wholesale lab access.
Establishing reliable baseline data in melanocortin receptor research depends directly on reagent quality. When searching to buy PT-141 Bremelanotide online, verifying third-party analytical testing, low endotoxin thresholds, and domestic synthesis origin ensures your laboratory avoids batch contamination and structural variations.
PX1 Research remains committed to supporting scientific inquiry by delivering uncompromising purity, absolute transparency, and consistent supply chains. All compounds are offered strictly for laboratory research, in vitro studies, and preclinical testing.
What is PT-141 Bremelanotide primary focus in preclinical research?
PT-141 (Bremelanotide) is primarily investigated as a non-selective melanocortin receptor agonist (focusing on MC3R and MC4R) to study central nervous system pathways linked to behavioral responses and neuroendocrine signaling.
How can researchers verify the purity of PT-141 Bremelanotide purchased online?
Purity verification requires a lot-specific Certificate of Analysis (COA) incorporating High-Performance Liquid Chromatography (HPLC) to confirm purity percentage (>99%) and Mass Spectrometry (MS) to verify correct molecular weight.
What target receptors does Bremelanotide bind to in vitro?
In vitro studies demonstrate that Bremelanotide binds with high affinity to melanocortin receptor subtypes MC4R and MC3R, as well as peripheral MC1R receptors.
What solvent is recommended for reconstituting lyophilized PT-141?
For standard laboratory handling, sterile Bacteriostatic Water or sterile 0.9% Sodium Chloride solution is typically used to reconstitute lyophilized Bremelanotide under aseptic conditions.
How should reconstituted Bremelanotide solutions be stored in the lab?
Reconstituted liquid solutions should be stored at 2°C to 8°C for short-term use (up to 30 days) or split into single-use aliquots and frozen at -80°C to prevent freeze-thaw degradation.
How does PT-141 differ structurally from Melanotan II?
Bremelanotide is a cyclic heptapeptide analog derived as a active metabolite of Melanotan II, modified structurally to alter receptor selectivity and reduce peripheral melanogenesis activity.
Are PX1 Research compounds tested for endotoxins?
Yes. Every lot undergoes independent LAL testing to ensure endotoxin levels remain strictly below standard experimental limits (<0.01 EU/mg), protecting cell cultures from inflammatory artifacts.
Are PT-141 peptides from PX1 Research suitable for human use?
No. All products sold by PX1 Research are intended strictly for laboratory research, in vitro experiments, and non-human animal models. They are never for human or therapeutic use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.